Metropolitan Life Insurance Company (MetLife)’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-27,621
| Closed | -$85.6K | – | 2823 |
|
|
2021
Q4 | $85.6K | Buy |
27,621
+4,666
| +20% | +$15.7K | ﹤0.01% | 2559 |
|
|
2021
Q3 | $82.9K | Buy |
22,955
+11,021
| +92% | +$41.6K | ﹤0.01% | 2627 |
|
|
2021
Q2 | $42.7K | Sell |
11,934
-13,526
| -53% | -$47.7K | ﹤0.01% | 2678 |
|
|
2021
Q1 | $99.5K | Buy |
25,460
+12,578
| +98% | +$51.9K | ﹤0.01% | 2430 |
|
|
2020
Q4 | $54.1K | Buy |
12,882
+234
| +2% | +$902 | ﹤0.01% | 2469 |
|
|
2020
Q3 | $47.2K | Sell |
12,648
-15,015
| -54% | -$63.9K | ﹤0.01% | 2472 |
|
|
2020
Q2 | $121K | Buy |
27,663
+9,773
| +55% | +$43.9K | ﹤0.01% | 2136 |
|
|
2020
Q1 | $67.8K | Sell |
17,890
-2,737
| -13% | -$13.4K | ﹤0.01% | 2263 |
|
|
2019
Q4 | $130K | Sell |
20,627
-9,420
| -31% | -$55.4K | ﹤0.01% | 2176 |
|
|
2019
Q3 | $126K | Buy |
30,047
+23,494
| +359% | +$100K | ﹤0.01% | 2167 |
|
|
2019
Q2 | $30.5K | Buy |
+6,553
| New | +$30.5K | ﹤0.01% | 2553 |
|
|
2016
Q2 | – | Sell |
-32,132
| Closed | -$104K | – | 2741 |
|
|
2016
Q1 | $104K | Buy |
32,132
+581
| +2% | +$2.15K | ﹤0.01% | 2419 |
|
|
2015
Q4 | $151K | Hold |
31,551
| – | – | ﹤0.01% | 2432 |
|
|
2015
Q3 | $175K | Buy |
31,551
+3,905
| +14% | +$28.8K | ﹤0.01% | 2376 |
|
|
2015
Q2 | $220K | Sell |
27,646
-4,340
| -14% | -$37.3K | ﹤0.01% | 2339 |
|
|
2015
Q1 | $336K | Hold |
31,986
| – | – | ﹤0.01% | 1775 |
|
|
2014
Q4 | $384K | Hold |
31,986
| – | – | ﹤0.01% | 1948 |
|
|
2014
Q3 | $547K | Sell |
31,986
-9,381
| -23% | -$136K | ﹤0.01% | 1664 |
|
|
2014
Q2 | $499K | Buy |
41,367
+14,741
| +55% | +$140K | ﹤0.01% | 1825 |
|
|
2014
Q1 | $225K | Buy |
+26,626
| New | +$215K | ﹤0.01% | 2394 |
|
Other funds holding BDSI
Metropolitan Life Insurance Company (MetLife)'s BDSI Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 27,621 shares — an estimated $85.6K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BDSI in Q1 2014 and held it in 20 quarters. The position peaked at $547K in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 27,621 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $85.6K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 20 quarters.
- Metropolitan Life Insurance Company (MetLife)'s BioDelivery Sciences International, Inc. position peaked at $547K in Q3 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.